Okairos(意大利)

Okairos

意大利Okairoswww.okairos.comOkairos公司有一个好的开端--自从从默沙东公司剥离出来后，它已得到来自BioMedlnvest、勃林格殷格翰（BoehringerIngelheim）公司风险基金、LSP、诺华（Novartis）公司风险基金和VersantVentures公司的支持。其疫苗技术在预防呼吸道合胞病毒和流感病毒方面也具有很大的潜力。目前已有许多生物技术公司在专注 于丙型肝炎疫苗的开发2013年GSK2.5亿欧元收购瑞士疫苗平台OkairosAG Weareaclinical-stagebiopharmaceuticalcompanyspunoutfromMerckin2007.OurheadquartersareinBaselandwehavelaboratoriesinRomeandNaples.Ourfounders,RiccardoCorteseandhisteam,werealsothefoundersofIstitutodiRicerchediBiologiaMolecolare(IRBM),whichlaterbecameasubsidiaryofMerckInc.WhileatIRBM,theymadesignificantcontributionstothefieldofinfectiousdiseases,includingelucidationofthemechanismofactionofthehepatitisCproteaseandpolymeraseenzymes,anddiscoveryoftheHIVfusioninhibitorISENTRESS®.Todaywearedevelopinggeneticvaccinesformajorinfectiousdiseases,includinghep